Previous close | 9.04 |
Open | 9.04 |
Bid | 8.67 x 200 |
Ask | 8.80 x 100 |
Day's range | 8.71 - 9.33 |
52-week range | 3.96 - 12.45 |
Volume | |
Avg. volume | 233,667 |
Market cap | 975.368M |
Beta (5Y monthly) | 1.45 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Aligning with EPS Projections, CNTA Reports a Net Loss Decrease in Q4
Karen Anderson, the Chief People Officer of Centessa Pharmaceuticals PLC (NASDAQ:CNTA), has sold 51,160 shares of the company on March 25, 2024, according to a recent SEC Filing.
Key Insights The considerable ownership by private equity firms in Centessa Pharmaceuticals indicates that they...